...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Liquidity
Reply New Message
Prev Message Back To Forum Threaded View Next Message

I agree with you 100%. As Don answered at 1 AGM - paraphrase 

Also, I was trying to flush out if going public now might have any risks such as someone(BP) taking a large position at a low price but that didn't seem possible to me given the dominant current shareholders so I did not see any risk to management control.

GLTA

Toinv

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply